SCHEMBL19081958

SCHEMBL19081958

c1cc(-c2c3ccccc3c(-c3cccc4ccccc34)c3ccccc23)cc(-c2cc3sc4ccc5ccccc5c4c3c3c2oc2ccccc23)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
AHR P35869 1/20 0.33
PAX8 Q06710 1/20 0.33
ALOX5 P09917 2/20 0.33
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
KMT2A Q03164 2/20 0.30
MAPK1 P28482 2/20 0.30
KDM4E B2RXH2 2/20 0.30
MEN1 O00255 1/20 0.30
TP53 P04637 1/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
NFKB1 P19838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19076698 0.88 MEN1 (0.31) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL19076697 0.86 ALOX5 (0.37) ALOX5ALDH1A1MAPTKDM4EHPGD
SCHEMBL19081564 0.84 ABCG2 (0.39) ABCG2TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL19081990 0.84 TDP1 (0.33) ABCG2TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL17932144 0.84 ALOX5 (0.39) ABCG2TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL19081994 0.82 CYP1A1 (0.38) ABCG2TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL19079966 0.81 ABCG2 (0.42) ABCG2TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL19081915 0.81 ABCG2 (0.34) ABCG2TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL17945216 0.80 S1PR5 (0.35) CYP1A1CYP1A2ALOX5
SCHEMBL10122305 0.80 ALOX5 (0.40) ABCG2TDP1L3MBTL1CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885TDP1 2322/4885L3MBTL1 1245/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885TDP1 2322/4885L3MBTL1 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.